{
    "nctId": "NCT04340180",
    "briefTitle": "Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction",
    "officialTitle": "Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Benign Tumor, Breast Malignant Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Compare lesion conspicuity on a scale of 1-4 from low-dose and SOC-dose imaging.",
    "eligibilityCriteria": "Inclusion Criteria for Breast Cancer Patients:\n\n* Female patient between \u2265 18 years old and \u2264 99 years old\n* Patients with newly diagnosed primary breast cancer\n* Patient able and willing to participate in the trial\n\nInclusion criteria for Non-malignant indications:\n\n* Female patients between \u2265 18 years old and \u2264 99 years old\n* Be referred for MRI for non-malignant indications (screening or BIRADS 3)\n* Patients have had prior exam with known enhancing mass, nonmass enhancement, or focus/foci.\n\nExclusion Criteria:\n\n* Non-female patients\n* Patients \\< 18 years old\n* Women who are lactating or pregnant\n* Patients with recurrent breast cancer\n* Patients who have already received neoadjuvant chemotherapy\n* Unable to lie still on the imaging table for one (1) hour\n* Patients that are unable to undergo MRI evaluation for reasons specific to MRI",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}